dailyai.report

The article claims that labeling every AI advance as 'progress' is a false assumption. It critiques the conflation of technology growth with societal benefit, citing the FDA as a cautionary example. The author urges careful policy framing to avoid unintended harm. Practitioners should treat AI gains as tools, not guarantees of improvement.